'Mitotherapy' for Heart Failure
- PMID: 26965961
- DOI: 10.1016/j.molmed.2016.02.007
'Mitotherapy' for Heart Failure
Abstract
Abnormalities in mitochondrial dynamics along with those for the molecular mediators involved are presently being viewed with increased interest in the field of cardiovascular disease. Recent research highlights OPA1, a dynamin-like GTPase mediating mitochondrial fusion, as well as the 'mitoproteases' OMA1 and YME1L, as potential therapeutic targets against heart failure.
Keywords: aging; heart; pathway.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Comment on
-
Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice.Science. 2015 Dec 4;350(6265):aad0116. doi: 10.1126/science.aad0116. Science. 2015. PMID: 26785494
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources